SEJAL BHULA: Open Payments
NPI 1164001582 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,809 in 108 payments from 17 companies in 2025. Trend: 2023 $2,066 · 2024 $2,975 · 2025 $1,809
Food & beverage: $1,809
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 14 | $291 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $245 |
| ABBVIE INC. | 22 | $216 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $166 |
| Supernus Pharmaceuticals, Inc. | 12 | $155 |
| Otsuka America Pharmaceutical, Inc. | 10 | $150 |
| Lundbeck LLC | 6 | $117 |
| Vanda Pharmaceuticals Inc. | 5 | $99 |
| Neurocrine BioSciences, Inc. | 5 | $98 |
| Bausch Health US, LLC | 4 | $83 |
Products named: Auvelity, REXULTI, CAPLYTA, VRAYLAR, TRINTELLIX, Qelbree, HETLIOZ, INGREZZA.
Industry payments across SC — which companies pay providers there.
